期刊文献+

淋巴细胞活化基因-3在骨髓增生异常综合征患者T细胞亚群中的表达 被引量:5

Lymphocyte activation gene 3 expression on T lymphocyte cell subsets in patients with myelodysplastic syndrome
原文传递
导出
摘要 目的探讨淋巴细胞活化基因-3(LAG3)在骨髓增生异常综合征(MDS)患者T细胞亚群中的表达。方法选取2019年1至11月期间于天津医科大学总医院血液科新诊断的MDS患者16例为MDS组,另纳入16名健康成人为健康对照组,采用流式细胞术检测CD8+T细胞、CD4+T细胞和调节性T细胞在MDS组和健康对照组中的表达水平。结果共纳入MDS患者16例;男5例,女11例;中位年龄56(18~80)岁。健康对照组16名,男女各8名,中位年龄40(17~69)岁,两组性别和年龄组成差异无统计学意义(均P>0.05)。LAG3在MDS组CD8+T细胞中的表达显著高于健康对照组(74.45%±22.31%比58.78%±14.82%,P<0.05)。LAG3在MDS组调节性T细胞中的表达显著高于健康对照组(64.91%±10.32%比49.09%±13.58%,P<0.05)。LAG3在CD4+T细胞中的表达MDS组与健康对照组间差异无统计学意义(P>0.05)。结论LAG3在MDS患者CD8+T和调节性T细胞上的表达高于健康人。 Objective To investigate the expression of Lymphocyte activation gene 3(LAG3)in myelodysplastic syndromes(MDS)patients.Methods A total of 16 MDS patients newly diagnosed in Hematology Department of Tianjin Medical University were enrolled from January to November 2019.The healthy control(HC)group includes 16 cases of healthy adults.The expression levels of LAG3 on CD8+T cells,CD4+T cells and regulatory T cells(Treg)in MDS patients and healthy controls were detected by flow cytometry.Results A total of 16 patients with MDS were included,including 5 males and 11 females,with a median age of 56(18-80)years old.HC group includes 16 healthy adults,8 men and 8 women,with a median age of 40(17-69)years.There was no statistically significant difference in gender and age composition between the two groups(both P>0.05).The expression of LAG3 on CD8+T cells in MDS patients(74.45%±22.31%)was significantly higher than that in HC group(58.78%±14.82%,P<0.05).The LAG3 expression on Treg in MDS patients(64.91%±10.32%)were significantly higher than that of HC group(49.09%±13.58%,P<0.05).There was no statistical difference in LAG3 expression on CD4+T cells between the two groups.Conclusion The expression of LAG3 on CD8+T cells and Treg increases in MDS patients than that of healthy people.
作者 谢凝 孙莹莹 江汇涓 刘春燕 邵宗鸿 Xie Ning;Sun Yingying;Jiang Huijuan;Liu Chunyan;Shao Zonghong(Tianjin Medical University,Tianjin 300070,China;Hematology Department,Tianjin Medical University General Hospital,Tianjin 300052,China)
出处 《中华医学杂志》 CAS CSCD 北大核心 2020年第24期1886-1889,共4页 National Medical Journal of China
基金 国家自然科学基金(81400088、81770118、81870101) 天津市自然科学基金(16JCZDJC35300)。
关键词 骨髓增生异常综合征 淋巴细胞活化基因-3 T淋巴细胞亚群 Myelodysplastic syndromes Lymphocyte activation gene 3 T-lymphocyte subsets
  • 相关文献

参考文献4

二级参考文献32

  • 1王化泉,邵宗鸿.免疫“妥协”和骨髓增生异常综合征细胞克隆[J].中华血液学杂志,2005,26(1):60-62. 被引量:8
  • 2王化泉,邵宗鸿,邢莉民,付蓉,涂梅峰,孙娟,贾海蓉.骨髓增生异常综合征患者外周血树突细胞数量、亚群及其表面协同刺激分子表达的研究[J].中华血液学杂志,2007,28(7):474-477. 被引量:3
  • 3Hamblin TJ. Immunology aspects of the myelodysplastic syndrome//Bennett JM. The myelodysplastic syndrome: pathobiology and clinical management. New York: Marcel Dekker, 2002 : 65- 88. 被引量:1
  • 4Jiang H, Chess L. Regulation of immune responses by T cell. N Engl J Med, 2006,354 : 1166-1176. 被引量:1
  • 5Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol, 2004, 22:531-562. 被引量:1
  • 6Curiel TJ, Coukos G, Zou L,et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med, 2004,10:942-949. 被引量:1
  • 7Wolf D, Wolf AM, Rumpold H,et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res, 2005,11:8326-8331. 被引量:1
  • 8Dannull J, Su Z, Rizzieri D,et al. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T eens. J Clin Invest, 2005,115:3623-3633. 被引量:1
  • 9Jonuleit H, Schmitt E. The regulatory T cell family: distinct subsets and their interrations. J Immunol, 2003, 171:63234-6327. 被引量:1
  • 10Tefferi A,Vardiman JW. Myelodysplastic syndromes[J].New England Journal of Medicine,2009.1872-1885. 被引量:1

共引文献14

同被引文献25

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部